CL
CORT icon

CIM LLC’s Corcept Therapeutics CORT Stock Holding History

CIM LLC’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$593K Buy
6,815
+215
+3% +$13K 0.08% 126
2026
Q1 		$266K Hold
6,600
– – 0.04% 150
2025
Q4 		$230K Sell
6,600
-402
-6% -$31.6K 0.03% 165
2025
Q3 		$582K Hold
7,002
– – 0.08% 113
2025
Q2 		$514K Sell
7,002
-4,374
-38% -$317K 0.07% 113
2025
Q1 		$1.3M Sell
11,376
-924
-8% -$56.2K 0.19% 82
2024
Q4 		$620K Sell
12,300
-3,143
-20% -$165K 0.09% 112
2024
Q3 		$715K Sell
15,443
-466
-3% -$16.6K 0.1% 104
2024
Q2 		$542K Buy
15,909
+130
+0.8% +$3.56K 0.08% 107
2024
Q1 		$397K Buy
15,779
+129
+0.8% +$3.05K 0.06% 116
2023
Q4 		$360K Buy
15,650
+1,411
+10% +$38.7K 0.06% 117
2023
Q3 		$388K Buy
14,239
+187
+1% +$5.41K 0.07% 112
2023
Q2 		$313K Buy
14,052
+350
+3% +$8.06K 0.06% 128
2023
Q1 		$297K Sell
13,702
-345
-2% -$7.56K 0.06% 128
2022
Q4 		$324K Sell
14,047
-333
-2% -$8.35K 0.06% 126
2022
Q3 		$431K Buy
14,380
+996
+7% +$26.7K 0.09% 109
2022
Q2 		$370K Buy
13,384
+3,678
+38% +$80.1K 0.08% 107
2022
Q1 		$234K Buy
+9,706
New +$206K 0.04% 133
2018
Q4 		– Sell
-10,973
Closed -$154K – 102
2018
Q3 		$154K Buy
+10,973
New +$153K 0.06% 113

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM LLC's CORT Position: Q2 2026 in Review

CIM LLC increased its Corcept Therapeutics (CORT) stake by 3.3% in Q2 2026, buying an estimated $13K and bringing the position to 6,815 shares worth $593K. The position accounts for 0.08% of the portfolio, ranked #126.

CIM LLC first reported a position in CORT in Q3 2018 and has held it in 19 quarters since. The position peaked at $1.3M in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • CIM LLC held 6,815 shares of Corcept Therapeutics worth $593K as of Q2 2026.
  • CIM LLC bought 215 Corcept Therapeutics shares in Q2 2026, an estimated $13K.
  • Corcept Therapeutics made up 0.08% of CIM LLC's portfolio in Q2 2026, its #126 holding.
  • CIM LLC first reported a position in Corcept Therapeutics in Q3 2018 and has held it in 19 quarters since.
  • CIM LLC's Corcept Therapeutics position peaked at $1.3M in Q1 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on CIM LLC's 13F filing for Q2 2026, filed 13 Aug 2026.